Eris Lifesciences to acquire Oaknet Healthcare for Rs 650 crore Ruchika Sharma4 May 2022 11:19 AM ISTMr Krishnakumar V, Executive Director & Chief Operating Officer of Eris Lifesciences Ltd., added, "The acquisition of Oaknet brings marquee brands...
Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Ruchika Sharma3 May 2022 4:05 PM ISTUnder the terms of the settlement agreement, Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain...
Pfizer's COVID drug Paxlovid fails to show benefit as preventive therapy Ruchika Sharma2 May 2022 10:58 AM ISTThe results were not statistically significant and thus possibly due to chance.
Bristol Myers Squibb gets USFDA nod for obstructive hypertrophic cardiomyopathy drug Camzyos Ruchika Sharma1 May 2022 10:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (USFDA) has approved Camzyos (mavacamten, 2.5 mg, 5...
Tamil Nadu: All Pharmacists Association stages protest, demanding 1200 vacancies to be filled MD Bureau30 April 2022 3:49 PM ISTTamil Nadu: The members of All Pharmacists Association of Tamil Nadu on Thursday staged a demonstration in the form of protest, demanding the...
Drug safety alert: IPC flags adverse reactions linked to Cefuroxime Susmita Roy29 April 2022 8:52 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of April, has revealed that a...
Drug alert: CDSCO flags 48 drugs as not of standard quality Susmita Roy28 April 2022 6:54 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 48 medicine...
CDSCO panel gives Emcure Pharma waiver on Phase IV CT for Lamivudine plus Dolutegravir Dr. Divya Colin27 April 2022 6:19 PM ISTNew Delhi: Pharmaceutical major, Emcure Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Pharma Bribe to doctors: SC tells Centre to give detailed reply on stand on UCPMP status Ruchika Sharma26 April 2022 5:36 PM IST"This Code is enforceable against doctors, however, does not apply to drug companies, leading to anomalous situations where doctors' licenses are...
Dr. Reddy's gets CDSCO panel nod to study Fosravuconazole L Lysine Ethanolate Capsule Dr. Divya Colin25 April 2022 8:06 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Novo Nordisk bags CDSCO panel nod to study anti neoplastic drug Concizumab Dr. Divya Colin24 April 2022 12:30 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
